• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Politicsabortion

U.S. states buying millions of doses of medication abortion drugs amid fears that courts could make them illegal

By
Steve LeBlanc
Steve LeBlanc
and
The Associated Press
The Associated Press
Down Arrow Button Icon
By
Steve LeBlanc
Steve LeBlanc
and
The Associated Press
The Associated Press
Down Arrow Button Icon
April 11, 2023, 6:10 AM ET
Massachusetts Governor Maura Healey
Massachusetts has purchased enough doses of the drug mifepristone — one of two drugs used in combination to end pregnancies — to last for more than a year, Democratic Gov. Maura Healey saidJessica Rinaldi—The Boston Globe/Getty Images

A growing number of states led by Democratic governors are stockpiling doses of drugs used in medication abortions, amid fears that a court ruling could restrict access to the most commonly used method of abortion in the U.S.

Massachusetts has purchased enough doses of the drug mifepristone — one of two drugs used in combination to end pregnancies — to last for more than a year, Democratic Gov. Maura Healey said Monday. California has secured an emergency stockpile of up to 2 million pills of misoprostol, the other drug used in abortion medication, Gov. Newsom, also a Democrat, announced.

And in Washington state, Democratic Gov. Jay Inslee announced last week that the state purchased 30,000 doses of the generic version of mifepristone — which he said is enough to last the state’s residents three years. The shipment arrived in late March.

“Abortion is still legal and accessible here in California and we won’t stand by as fundamental freedoms are stripped away,” Newsom said Friday.

The actions come as U.S. District Judge Matthew Kacsmaryk, a Trump appointee in Amarillo, Texas, overruled decades of scientific approval Friday and put on hold federal approval of mifepristone.

The judge stayed his ruling for a week so federal authorities could file a challenge.

The Biden administration slammed the ruling and on Monday appealed the decision, saying it would thwart the U.S. Food and Drug administration’s scientific judgment and “severely harm women, particularly those for whom mifepristone is a medical or practical necessity.”

Adding to the confusion was a second opinion also released on Friday by District Judge Thomas O. Rice, an Obama appointee, directing U.S. authorities not to make any changes that would restrict access to the drug in at least 17 states where Democrats sued in an effort to protect availability.

Healey said the Kacsmaryk ruling threatens access to the medication even in states supportive of abortion rights like Massachusetts.

“It harms patients, undermines medical expertise, and takes away freedom. It’s an attempt to punish, to shame, to marginalize women. It’s unnecessary,” Healey said, surrounded by fellow Democratic lawmakers including U.S. Sen. Elizabeth Warren on the steps of the Massachusetts Statehouse.

“It is terrible. It is terrible,” she added.

Newsom said the ruling by Kacsmaryk “ignores facts, science, and the law,” and puts the health of millions of women and girls at risk.

Inslee said it’s important for states to take steps to ensure access to the drug.

“After we announced our actions last week to protect access to mifepristone, it’s heartening to see other states doing the same,” Inslee wrote on Twitter on Monday. “To be clear: no matter the outcome of the TX case, WA’s laws ensure we will be able to sell and distribute this medication.”

The 15,000 doses in Massachusetts were purchased by the University of Massachusetts-Amherst at Healey’s request.

Massachusetts health care providers have also agreed to buy additional quantities of mifepristone, according to Healey, who said the administration is dedicating $1 million to help providers contracted with the Department of Public Health to pay for the doses.

While there are no plans yet in Connecticut to stockpile mifepristone, Attorney General William Tong said Monday that he has been contacting major pharmacy chains to remind them the drug is legal and they should not be influenced by pressure from GOP attorneys general in other states.

”(I’m) obviously deeply disappointed that my colleagues have taken that action,” he said. “We’re pushing back on that. We’re in communication with all the big pharmacy chains, advising them of their rights and obligations here in Connecticut.”

Also on Friday, Healey signed an executive order expanding a 2022 law meant to build a legal firewall around abortion services — protecting health care providers, patients and pharmacists from out-of-state investigations into medication abortions. The law was signed after the U.S. Supreme Court ruling overturning Roe v. Wade.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Authors
By Steve LeBlanc
See full bioRight Arrow Button Icon
By The Associated Press
See full bioRight Arrow Button Icon

Latest in Politics

EconomyFederal Reserve
Trump names Warsh, Hassett as top Fed contenders, WSJ says
By Jennifer A. Dlouhy and BloombergDecember 12, 2025
5 hours ago
PoliticsMilitary
Trump says ‘starting’ land strikes over drugs in latest warning
By Justin Sink and BloombergDecember 12, 2025
5 hours ago
EconomyFederal Reserve
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
7 hours ago
Trump
PoliticsWhite House
House Democrats release new Epstein photos including Trump, Clinton, Prince Andrew
By Stephen Groves and The Associated PressDecember 12, 2025
8 hours ago
Sherrone Moore
LawMichigan
Michigan mystery revealed: Fired football coach had broken into a lover’s apartment and threatened to kill himself when their affair ended
By Ed White and The Associated PressDecember 12, 2025
8 hours ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
9 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
18 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
placeholder alt text
Success
Palantir cofounder calls elite college undergrads a ‘loser generation’ as data reveals rise in students seeking support for disabilities, like ADHD
By Preston ForeDecember 11, 2025
2 days ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
14 hours ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
13 hours ago
placeholder alt text
Arts & Entertainment
'We're not just going to want to be fed AI slop for 16 hours a day': Analyst sees Disney/OpenAI deal as a dividing line in entertainment history
By Nick LichtenbergDecember 11, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.